Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Neoplasms 9Depression 9Anxiety Disorders 7Neoplasm Metastasis 3Melanoma 2Depressive Disorder, Major 2Wounds and Injuries 1Trauma, Nervous System 1Stress Disorders, Post-Traumatic 1Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1Osteosarcoma 1Opioid-Related Disorders 1Lymphoma 1Hospice 1Hematopoietic and Lymphatic System Neoplasm 1Hematologic Neoplasms 1Gastrointestinal Neoplasms 1Endocrine Gland Neoplasms 1Depressive Disorder 1Caregiver Distress 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Biliary Tract Neoplasms 1Agnosia 1

Interventions

Venlafaxine Hydrochloride 1Specimen Handling 1Selective Serotonin Reuptake Inhibitors 1Psilocybin 1Interviews as Topic 1Dignity Therapy 1Counseling 1Antidepressive Agents, Tricyclic 1Antidepressive Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Depressive Disorder × Psilocybin × Clear all
NCT07216404 2026-05-14

Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting
10 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Depressive Disorder

Data powered by HemOnc (CC BY 4.0) Colophon âš¡